These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20158687)

  • 1. Lipidomic analysis of platelet senescence.
    Ruebsaamen K; Liebisch G; Boettcher A; Schmitz G
    Transfusion; 2010 Aug; 50(8):1665-76. PubMed ID: 20158687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles.
    Pienimaeki-Roemer A; Ruebsaamen K; Boettcher A; Orsó E; Scherer M; Liebisch G; Kilalic D; Ahrens N; Schmitz G
    Transfusion; 2013 Mar; 53(3):612-26. PubMed ID: 22804622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
    Pienimaeki-Roemer A; Kuhlmann K; Böttcher A; Konovalova T; Black A; Orsó E; Liebisch G; Ahrens M; Eisenacher M; Meyer HE; Schmitz G
    Transfusion; 2015 Mar; 55(3):507-21. PubMed ID: 25332113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
    Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
    Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pH on stored human platelets.
    Dekkers DW; De Cuyper IM; van der Meer PF; Verhoeven AJ; de Korte D
    Transfusion; 2007 Oct; 47(10):1889-95. PubMed ID: 17880616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periods without agitation diminish platelet mitochondrial function during storage.
    Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Moroff G; Wagner SJ
    Transfusion; 2010 Feb; 50(2):390-9. PubMed ID: 19874561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis.
    Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R
    Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
    Albanyan AM; Harrison P; Murphy MF
    Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets.
    Dumont LJ; Gulliksson H; van der Meer PF; Murphy S; Nixon JG; de Wildt-Eggen J; Vandenbroeke T; Aubuchon JP
    Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet ADP response deteriorates in synthetic storage media.
    Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
    Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
    Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
    Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days.
    Valeri CR; Ragno G; Marks PW; Kuter DJ; Rosenberg RD; Stossel TP
    Transfusion; 2004 Jun; 44(6):865-70. PubMed ID: 15157253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
    Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
    Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
    Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
    Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
    Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired cytochrome C oxidase impairment in apheresis platelets during storage: a possible mechanism for depletion of metabolic adenosine triphosphate.
    Diab YA; Thomas A; Luban NL; Wong EC; Wagner SJ; Levy RJ
    Transfusion; 2012 May; 52(5):1024-30. PubMed ID: 22098205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.